Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226

NeuroReport

Volumn 7, Issue 4, 1996, Pages 901-904

  Dumont, Yvan ^a   St Pierre, Jacques André ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Autoradiographic distribution; Non peptide antagonist; NPY Y1 receptor; Y1 agonist; Y1 antagonist

Indexed keywords

IODINE 125; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y1 RECEPTOR; PEPTIDE YY; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; AUTORADIOGRAPHY; IODINE RADIOISOTOPES; MALE; NEUROPEPTIDE Y; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; TRITIUM;

EID: 0029924719     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199603220-00013     Document Type: Article

References (21)

1. Tatemoto K, Carlquist M and Mutt V. Nature 296, 659-660 (1982).
2. Dumont Y, Martel JC, Fournier A et al. Prog Neurobiol 38, 125-127 (1992).
3. Wahlestedt C, and Reis DJ. Annu Rev Toxicol 32, 309-352 (1993).
4. Gehlert H. Life Sci 55, 551-562 (1994).
5. Grundemar L, Sheikh SP and Wahlestedt C. Characterization of receptor types for neuropeptide Y and related peptides. In: Colmers WF and Wahlestedt C, eds. The Biology of Neuropeptide Y and Related Peptides Totowa, NJ: Humana Press, 1993: 197-240.
6. Heilig M, Neuropeptide Y in relation to behaviour and psychiatric disorders: some animal and clinical observations. In: Colmers WF and Wahlestedt C, eds, The Biology of Neuropeptide Y and Related Peptides. Totowa, NJ: Humana Press, 1993: 511-555.
7. Schoober DA, Lundell I, Schimdt R et al. Soc Neurosci Abstr 21, 1594 (1995).
8. Walker MW, Gerald C, Bard JA et al. Soc Neurosci Abstr 21, 1012 (1995).
9. Lundell T, Blomqvist AG, Berglund M et al. Soc Neurosci Abstr 21, 1594 (1995).
10. Dumont Y, Cadieux A, Pheng LH et al. Mol Brain Res 26, 320-324 (1994).
11. Dumont Y, Fournier A, St-Pierre S et al. J Pharmacol Exp Res 272, 673-680 (1995).
12. Dumont Y, Fournier A, St-Pierre S et al. Synapse In Press, (1995).
13. Rudolf K, Eberlein W, Engel W et al. Eur J Pharmacol 271, R11-R13 (1994).
14. Jacques D, Cadieux A, Dumont Y et al. Eur J Pharmacol 278, R3-R5 (1995).
15. Entzeroth M, Braunger H, Eberlein W et al. Eur J Pharmacol 278, 239-242 (1995).
16. Gackenheimer SL, Lundell I, Schmidt R et al. Soc Neurosci Abstr 21, 1593 (1995).
17. Jorgensen JC, Fuhlendorff J and Schwartz TW. Eur J Pharmacol 186, 105-114 (1990).
18. Whitcomb DC, Taylor IL and Vigna SR. Am J Physiol 22, G687-G691 (1990).
19. Forest M, Martel JC, St-Pierre S et al. J Med Chem 33, 1615-1618 (1990).
20. Dumont Y, Fournier A, St-Pierre S et al. J Neurosci 13, 73-86 (1993).
21. Dumont Y and Quirion R. Physiologist 38, A-248 (1995).